US2014031313A1PendingUtilityA1
Mimicking the Metabolic Effects of Caloric Restriction by Administration of Glucose Anti-Metabolites
Est. expiryJul 8, 2017(expired)· nominal 20-yr term from priority
A61P 3/02A61P 3/00A61P 19/00A61P 21/00A61K 31/7004A23K 50/40A61K 31/716A23K 20/163
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of maintaining and/or attenuating a decline in the quality of life of a mammal comprising the step of administering to the mammal a composition comprising an effective amount of mannoheptulose wherein the effective amount of mannoheptulose provides a dosage to the mammal on a daily basis from about 0.001 gram per kilogram of body weight of the mammal to about 1 gram per kilogram of body weight of the mammal.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of maintaining and/or attenuating a decline in the quality of life of a mammal, said method comprising the step of administering to said mammal a composition comprising an effective amount of mannoheptulose wherein said effective amount of mannoheptulose provides a dosage to said mammal on a daily basis from about 0.001 gram per kilogram of body weight of said mammal to about 1 gram per kilogram of body weight of said mammal, wherein said maintaining and/or attenuating a decline in the quality of life of said mammal is selected from the group consisting of maintaining and/or attenuating a decline in whole body composition, maintaining and/or attenuating a decline in functional mobility, and combinations thereof.
2 . A method of maintaining and/or attenuating a decline in whole body composition in a mammal, the method comprising the step of administering to said mammal a composition comprising an effective amount of mannoheptulose wherein said effective amount of mannoheptulose provides a dosage to said mammal from about 0.001 gram per kilogram of body weight of said mammal to about 1 gram per kilogram of body weight of said mammal per day.
3 . A method of maintaining and/or attenuating a decline in musculoskeletal health in a mammal, said method comprising the step of administering to said mammal a composition comprising an effective amount of mannoheptulose wherein said effective amount of mannoheptulose provides a dosage to said mammal from about 0.001 gram per kilogram of body weight of said mammal to about 1 gram per kilogram of body weight of said mammal per day.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.